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Abstract
Background: Dot1L, a histone methyltransferase that targets histone H3 lysine 79 (H3K79), has been implicated in gene
regulation and the DNA damage response although its functions in these processes remain poorly defined.
Methodology/Principal Findings: Using the chicken DT40 model system, we generated cells in which the Dot1L gene is
disrupted to examine the function and focal recruitment of the 53Bp1 DNA damage response protein. Detailed kinetic and
dose response assays demonstrate that, despite the absence of H3K79 methylation demonstrated by mass spectrometry,
53Bp1 focal recruitment is not compromised in these cells. We also describe, for the first time, the phenotypes of a cell line
lacking both Dot1L and 53Bp1. Dot1L
2/2 and wild type cells are equally resistant to ionising radiation, whereas 53Bp1
2/2/
Dot1L
2/2 cells display a striking DNA damage resistance phenotype. Dot1L and 53Bp1 also affect the expression of many
genes. Loss of Dot1L activity dramatically alters the mRNA levels of over 1200 genes involved in diverse biological functions.
These results, combined with the previously reported list of differentially expressed genes in mouse ES cells knocked down
for Dot1L, demonstrates surprising cell type and species conservation of Dot1L-dependent gene expression. In 53Bp1
2/2
cells, over 300 genes, many with functions in immune responses and apoptosis, were differentially expressed. To date, this is
the first global analysis of gene expression in a 53Bp1-deficient cell line.
Conclusions/Significance: Taken together, our results uncover a negative role for Dot1L and H3K79 methylation in the DNA
damage response in the absence of 53Bp1. They also enlighten the roles of Dot1L and 53Bp1 in gene expression and the
control of DNA double-strand repair pathways in the context of chromatin.
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Introduction
In eukaryotic cells, DNA is present in a DNA-protein complex
known as chromatin [1]. The building block of chromatin is the
nucleosome. This structure consists of 147 bp of DNA wrapped
around a histone octamer that contains two molecules each of the
histones H2A, H2B, H3, and H4 [1,2]. Chromatin is the
physiological template for all DNA metabolic processes and
chromatin structure is modulated via a number of mechanisms to
regulate access to DNA [3]. These mechanisms include ATP-
dependent chromatin remodelling [4], incorporation of histone
variants [5] and several covalent modifications of histone residues
(methylation, acetylation, phosphorylation, ubiquitination and
sumoylation) [3].
Histone methylation occurs at a number of lysine and arginine
residues [6]. One such residue is lysine 79 of histone H3 (H3K79).
This modification was first identified in budding yeast and is
conserved from budding yeast to human [7,8,9,10,11]. H3K79
methylation is catalysed by the enzyme DOT1L/KMT4, which
adds one, two, or three methyl groups to generate H3K79me1,
me2, and me3 respectively [7,8,12,13]. The enzyme exhibits three
distinctive features compared to other histone methyltransferases.
Firstly, it displays histone methyltransferase (HMTase) activity
exclusively towards histone H3 that is incorporated into
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H3K79, is present in the a1 helix of the histone H3 globular core,
unlike most well characterised histone modifications which occur
on the exposed histone tails [3]. Thirdly, DOT1L is the only
known lysine HMTase that does not possess a SET domain [14].
Instead, it contains an S-adenosyl methionine (SAM) binding
domain similar to those found in arginine methyltransferases [15].
Mutation or deletion of this domain in DOT1L completely
abrogates its histone methyltransferase activity [7,8,13,16].
H3K79 methylation is involved in DNA metabolic processes
such as the regulation of gene expression and the response to DNA
damage in both yeast and higher eukaryotes. Cells are constantly
exposed to a barrage of both exogenous and endogenous
genotoxic agents that result in DNA damage [17]. To overcome
the deleterious effects of this damage, cells have evolved complex
signalling networks to detect and repair DNA damage before the
cell divides [17]. These DNA damage response pathways play
major roles in the maintenance of genomic integrity and tumour
suppression.
53BP1 is a tumour suppressor protein that functions in
checkpoint activation and DNA repair [18,19]. The protein
provides a direct link between chromatin and the DNA damage
response, as 53BP1 is recruited specifically to sites of DNA damage
through binding of its tandem Tudor domains to methylated
histone residues. Histone-mediated recruitment of 53BP1 remains
controversial. One of the residues implicated in this recruitment is
methylated H3K79 [20]. Indeed, abrogation of H3K79me
through siRNA knockdown of DOT1L in human cells has been
reported to completely abolish 53BP1 focal recruitment [20].
However, contrary to these results, others have reported that
H3K79 methylation is not involved in this process [21]. Instead,
these studies concluded that 53BP1 binds directly to dimethylated
histone H4 lysine 20 (H4K20me2) [21,22,23]. However, none of
these studies completely excluded the possibility that both
H3K79me and H4K20me might be involved in the recruitment
of 53BP1. Further work is therefore important to assess the relative
contributions of H3K79 and H4K20 methylation to 53BP1
recruitment at sites of DNA damage.
Interestingly, functions for both of these methylated histone
residues in the DNA damage response have been conserved in
evolution. In budding yeast, which does not possess H4K20
methylation [24], H3K79 methylation is required for activation
of the 53BP1-related protein Rad9 and its mobilisation to sites of
DNA damage [25,26,27]. Conversely, in fission yeast, which
lacks a DOT1L homologue and H3K79 methylation [28],
recruitment of the 53BP1-related protein Crb2 to regions of
DNA damage occurs, at least in part, via binding to methylated
H4K20 [28,29].
DOT1L and H3K79 methylation also affect gene expression. In
wild-type budding yeast, H3K79 methylation is extremely
abundant (about 90% of H3 molecules are K79-methylated) and
present throughout euchromatin, but is conspicuously absent from
heterochromatic regions such as the silent mating type loci and
sub-telomeric regions [13,30]. The rationale behind this localisa-
tion pattern is that H3K79 methylation prevents inappropriate
binding of the heterochromatic SIR proteins to euchromatic loci
[13]. Consequently, budding yeast cells that lack H3K79
methylation or overexpress Dot1 cannot confine SIR proteins to
heterochromatin, which leads to silencing defects of sub-telomeric
and silent mating type reporter genes [8,11,12,13,30,31,32,33,34].
An additional consequence of SIR protein dissociation from
heterochromatin in cells lacking H3K79 methylation is that they
are now able to roam free throughout the nucleus and potentially
interfere with expression of euchromatic genes.
Although much less abundant than in yeast cells (see Results),
H3K79 methylation also influences heterochromatin structure in
higher eukaryotes [35]. Surprisingly, despite the fact that Dot1L
specifically methylates H3K79, the abundance of heterochroma-
tin-specific histone marks, such as H4K20me3, is reduced in
Dot1L-deficient mouse ES cells [35]. In addition, hypermethylation
of H3K79 at the mouse HoxA9 locus increases transcription of this
gene [36]. In contrast, at the mouse EnaCa locus, increased levels
of H3K79 methylation actually reduce gene expression [37].
Therefore, it does appear that the influence of H3K79 methylation
on gene expression in vertebrate cells is locus-dependent. In
vertebrates, it is possible that the impact of H3K79 methylation on
gene expression depends on ill-defined aspects of the surrounding
chromatin environment [9].
Clearly, the functions of H3K79 methylation in the DNA
damage response and gene expression are far from resolved and this
is particularly true in vertebrate cells. To further our understanding
of the role of the Dot1 HMTase in these processes, we generated
novel vertebrate cell lines lacking Dot1L and H3K79 methylation.
We used the DT40 cell line derived from chicken lymphocytes
[38,39].Thesecellspresenta numberofadvantagesthat make them
an invaluable model system for geneticstudies in vertebratecells. Of
particular relevance here, is their high frequency of homologous
recombination (HR), which facilitates gene targeting and the
generation of cell lines with specific gene knockouts. In addition,
studies of chicken DT40 cell lines do not suffer from drawbacks of
mouse or human cell lines, such as off-targets effects and incomplete
sh/siRNA-mediated mRNA knockdown or contamination of ES
cells by feeder cells. Here, we exploited a novel DT40 Dot1L
2/2 cell
line to conduct detailed kinetic and DNA damage dose response
assays not previously performed in other model systems. We
demonstrate that 53Bp1 recruitment to sites of DNA damage
caused by ionising radiation is not compromised in cells lacking
Dot1L. For the first time, we also report studies of cells deficient in
both53Bp1andDot1L.Surprisingly,althoughabrogationofDot1L
function alone does not alter survival following DNA damage,
53Bp1
2/2/Dot1L
2/2 double mutant cells display a striking
resistance to ionising radiation. Microarray analysis of 53Bp1
2/2
and Dot1L
2/2 cell lines shows that 53Bp1 and Dot1L both affect
gene expressionandthatDot1L
2/2 cellsexhibitdramaticallyaltered
expression of many RNAs.
Materials and Methods
Cell lines
Cell lines were created in the DT40 wild-type background, also
known as WT18. Dot1L
2/2 and 53Bp1
2/2Dot1L
2/2 cell lines
were also generated in the Cre1-DT40 WT cell line [40,41] to
facilitate future generation of multiple knockout cell lines. Cre1-
DT40 WT cells express the Cre1 recombinase that can translocate
into the nucleus in response to 4-hydroxytamoxifen. This
recombinase [42] will recognise tandem repeats of LoxP sites and
allow the removal of DNA located between the two repeats. This
property allows multiple use of the same selective cassette
surrounded by LoxP sites (Figure 1A). Note that the Cre1-DT40
WT cell line has some limitations including a defective response to
nocodazole and an ionizing radiation-induced centrosome ampli-
fication phenotype [43]. Importantly, Cre1-DT40 WT cells
display the same survival rate [43] and cH2AX/53Bp1 focal
accumulation as WT18 cells (Figures S6 and S7). All experiments
shown in the manuscript were performed with cell lines in the
WT18 background. The only exception was the quantification of
cH2AX and 53Bp1 foci formation, which were performed in
Cre1-DT40 WT and Cre1-DT40 Dot1L
2/2 cells in comparison
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Cre1-DT40 Dot1L
2/2 cells, both cH2AX and 53Bp1 foci were
obtained in the WT18 Dot1L
2/2 cell line (data not shown).
Cell culture
DT40 cell lines were cultured at 39.5uC and 5.0% CO2 under
humidified conditions in RPMI 1640 (with L-glutamine and
sodium bicarbonate), 10% foetal bovine serum (FBS), 1% chicken
serum, 100 U/ml penicillin, and 100 mg/ml streptomycin. Media
and supplements were obtained from either Sigma (Dublin,
Ireland) or Lonza (Berkshire, UK).
Construction of targeting vectors
The sequence of the chicken Dot1L locus was obtained from the
NCBI (NM_032482.1) and Ensembl (ENSGALG00000000843)
chicken genome databases. The Dot1L targeting vectors pLox-
BLASTDot1L, pLoxNEODot1L, and pBSHygroDot1L were
constructed to delete 3.4 kb of genomic sequence encompassing
exons 5 and 6 (Figure 1A). A 3.8 kb region present upstream of the
targeted site was amplified from genomic DNA by PCR using the
forward primer 59-GACGGTACCTGACTAGCTAAATCCCA-
GATCTCAAGCTTGCTATGG-39, which contained a KpnIs i t e
and the reverse primer 59-GACGTCGACTTAGCTAGTCAG-
TGTTCAGCTTCATCGGTTGGGTG-39, which contained a
SalI site. This PCR product was inserted, as a KpnI-SalI fragment,
upstream of the resistance cassettes of the pLOXBLAST,
pLOXNEO [41] and pBSHygro plasmids. Similarly, a 5.8 kb
region downstream of the targeted site was amplified from genomic
DNA by PCR using the forward primer 59-GACACTAGTTGAC-
TAGCTAACCGCAGCCACGAACTGCAAACATC-39, which
contained an SpeI site and the reverse primer 59-GACGCGGCC-
GCTGACTAGCTAAGCACGGCGATGCCCATTACTGC-39,
which contained a NotI site. This PCR product was inserted as an
SpeI-NotI fragment downstream of the resistance cassettes of the
targeting vectors. Primers also contained stop codons in all six
reading frames. Transfection was performed by electroporation of
KpnI-linearised targeting constructs using the Gene Pulsar electro-
poration apparatus (Bio-Rad, Wicklow, Ireland). Southern blotting
was carried out using a probe external to the targeting construct.
The probe was labeled with either [a-
32P] or digoxigenin (PCR Dig
probe synthesis kit, Roche, Germany) and amplified using the
forward primer Dot1paprobeF 59-GAGCCTATACCCTTCTGA-
CACTTG-39andthereverseprimerDot1paprobeR59-GCACTG-
CAATCACGC TTGTAAGAC-39.
Figure 1. Generation of Dot1L deficient cell lines. A. Schematic of the strategy to disrupt the chicken Dot1L SAM binding domain and confirm
the deletion by Southern blotting. Exons are numbered. Bsr: blasticidin resistance gene; Hph: hygromycin resistance gene. EV: EcoRV restriction sites.
Grey rectangle: probe for Southern blots. The figure is approximately drawn to scale. B. Southern blot to confirm targeted integration of the Dot1L
disruption constructs. Digestion of the WT Dot1L locus with EcoRV generates a band of 13.2 kb when hybridised with the probe shown in A.
Following targeted integration of the blasticidin construct, the size of the band increases to 16.4 kb. Targeted integration of the hygromycin
construct results in a band of 11.4 kb. C. Reverse transcription PCR of the indicated exons of Dot1L in WT and Dot1L
md/md cells. D. RT-qPCR to quantify
the levels of Dot1L RNA in WT and Dot1L
md/md cell lines.
doi:10.1371/journal.pone.0014714.g001
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containing the human DOT1L cDNA under the control of the
CMV promoter (a kind gift from Dr. Yi Zhang, UNC Chapel Hill,
USA), endotoxin-free circular plasmids and the Amaxa cell line
nucleofection kit T (Lonza, Berkshire, UK), as described in the
manufacturers’ protocol.
Proliferation and clonogenic survival analysis
For cell proliferation analysis, cultures were seeded in triplicate
at equal cell densities (1610
4 cells/ml or 1610
5 cells/ml) and
counted using a haemocytometer every 24 hours. Survival of cells
following ionizing radiation was determined by clonogenic survival
assays in methylcellulose medium after exposure to a
137Cs
irradiator (Mainance Engineering Ltd, UK) at a dose rate of
21.57 Gy/minute. Colonies formed by surviving cells were
counted 7–10 days later.
Peptides, antibodies and recombinant H3
Western blotting was performed using antibodies recognising
monomethylated (anti-H3K79me1, ab2886, Abcam), dimethy-
lated (anti-H3K79me2, ab3594, Abcam), and trimethylated
(anti-H3K79me3, ab2621, Abcam) lysine 79 of histone H3, or a
C-terminal peptide of H3 (anti-H3, ab1791, Abcam). H3K79-
methylated peptide (H3K79me1 - ab4555, H3K79me2 - ab4556,
Abcam) concentrations were assessed by measuring their absor-
bance at 205nm. H4K20-methylated peptide (H4K20me0 –
ab14963, H4K20me1 – ab17043, H4K20me2 – ab14964,
H4K20me3 – ab17567) concentrations were determined by
measuring their absorbance at 230 nm in a Nanodrop spectro-
photometer. Recombinant histone H3 was a generous gift from
Dr. Andrew Flaus.
Immunofluorescence microscopy
Cells were irradiated or mock-treated and adhered to poly-L-
lysine coated slides before fixation in 4% paraformaldehyde. Cells
were permeabilised in 0.125% Triton-X-100 and non-specific
antibody binding blocked with 1% BSA. Cells were then
incubated with affinity purified anti-chicken 53Bp1 [44] or anti-
cH2AX mouse monoclonal antibodies (Millipore). FITC- and
Texas Red-conjugated secondary antibodies (Jackson Immunor-
esearch) were used. Images were acquired using the Olympus
BX51 microscope and Openlab software (Improvision). 0.4 mmZ -
stacks were collected and merged. All foci and cell percentages
were determined by blind-counting 50–100 cells per sample.
Histone preparation and protein digestion
Histones from DT40 cells were prepared from 10
7 cells and
digested as previously described [45]. The quality of histone
preparations (2–4 mg/ml of the 4 equimolar core histones) and the
purification yield (45–65%) were evaluated on a Coomassie-stained
gel (not shown). Intact core histones (approximately 10 mgo fa c i d -
extracted total protein) were separated using an Agilent 1100 HPLC
system equipped with a micro-fraction collector. Separations were
performed on a microbore Biobasic C18 column (5 mm, 300A ˚),
15061 mm i.d., with a solvent system consisting of 0.1% TFA in
water (v/v) (solvent A) and 0.1% TFA in acetonitrile (v/v) (solvent B).
Gradient elution was performed from 5–70% B in 60 minutes at
15 ml/min. Fractions were collected in a 96-well plate in 30 second
time slices. The fractions containing each core histone peak were
pooled together. Fractions were dried in a Speed-Vac. Proteins were
resuspended in 0.1 M ammonium bicarbonate (without pH
adjustment). This protein solution was derivatized in a 1:1 volume
ratio using propionic anhydride. After a 30 minutes at ambient
temperature, samples were dried a second time, resuspended in
0.1 M ammonium bicarbonate, and digested overnight at 37uCu si n g
1 mg of trypsin. Samples were acidified with 5% TFA in water (v/v)
prior to mass spectrometry (MS) analysis. Based on the fact that
peptides generated by trypsin cleavage of non-methylated or mono-
methylated H3K79 or H4K20 were observed in much lower
amounts than the propionylated peptides, we conclude that
propionylation of H3K79 and H4K20 nearly went to completion.
This is an important control because a low efficiency of propionyla-
tion would lead to an overestimation of the abundance of di- and tri-
methylation relative to non-methylated and mono-methylated
molecules. Without propionylation, the latter would be cut by trypsin
after H3K79 and H4K20 and, therefore, excluded from our analysis.
Global LC-MS/MS analysis of histone H3 fractions
Histone H3 tryptic digests were injected onto a Thermo
Electron LTQ-Orbitrap XL mass spectrometer equipped with a
nano electrospray interface. The instrument was operated in
positive ion mode with a one-second survey scan from m/z 300 to
1600 at 60 000 resolution. The survey scan was followed by MS/
MS in data dependent mode on the three most intense precursor
ions within the LTQ ion trap. Liquid chromatography was
performed using an Eksigent nano LC system. The trapping
(4cm6360 mm i.d.) and analytical columns (10cm6150 mm i.d.)
were packed in-house using teflon fused silica tubing and
Phenomenex Jupiter C18 (5 mm, 300A ˚) material. The solvent
system consisted of 0.2% formic acid in water (v/v) (solvent A) and
0.2% formic acid in acetonitrile (v/v) (solvent B). Gradient elution
was performed from 0–50% B in 60 minutes at 600 nL/min. Raw
LC-MS data files were converted to mgf file format and then
submitted to Mascot for protein identification.
Global FAIMS-MS/MS analysis of histone H4 fractions
Histone H4 tryptic digests were dried and resuspended in 50:50
methanol:water containing 0.2% formic acid (v/v). The Eksigent
nano LCseparation module was removed and replaced bya FAIMS
module. Samples were introduced into the FAIMS instrument by
direct infusion using a syringe pump operated at 600 nL/min. The
LTQ-Orbitrap XL mass spectrometer was fitted with a nano
electrospray interface. The instrument was operated in positive ion
mode, and programmed to perform full scan acquisition from m/z
200 to 1600 while ramping the FAIMS compensation voltage (CV)
from 250 to 0 V. Tandem MS was performed on a targeted list of
histone H4 tryptic peptides for sequence confirmation.
Targeted LC-MS/MS analysis of histone H3 fractions using
MRM
To determine their abundance accurately, specific histone H3
tryptic peptides were quantified by multiple reaction monitoring
(MRM) [46] using the MIDAS strategy on an AB/MDS
Analytical Technologies 4000 Q-trap hybrid triple quadrupole-
linear ion trap mass spectrometer equipped with a Nanospray II
interface. Separations were performed using an Agilent 1100
HPLC system with dynamic flow splitting. All columns and
solvents were identical to those listed under ‘‘global LC-MS/MS
analysis of histone H3 fractions’’. Chicken histone H3 sequences
from the Swiss-Prot database were imported into the MRM pilot
software. The 4 most intense b and/or y fragment ions were
chosen to generate theoretical MRM transitions in the Analyst
software. A ten-millisecond dwell time was used to monitor the
MRM transitions. The MRM experiment was followed by an
enhanced product ion (EPI) scan in IDA mode to confirm the
sequences of the detected peptides.
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RNA was extracted from cells using TriReagent (Invitrogen,
Paisley, UK). A cDNA pool was generated by reverse transcription
using the Superscript First-Strand Synthesis kit (Invitrogen,
Paisley, UK). Reverse transcription (RT) was primed using
oligo-dT primers according to the manufacturer’s protocols.
Primers used to amplify Dot1L cDNA fragments were: Exon2F
59 GACAAACACCATGATGCTGCTCATG-39, Exon4R 59-
CTGATGGATGCTGTCGATGGCG-39, Exon8F 59-GAGGT-
GACTTCCTCTCAGAAGAATGG-39, Exon10R 59-CGACT-
GTTAATTCTGAAATTCAGAGGTG-39.
Microarray analysis
Total RNA samples were prepared using TriReagent (Invitro-
gen, Paisley, UK), subjected to DNaseI digestion and further
purified using Qiagen RNAEasy columns (Qiagen, West Sussex,
UK). RNA quality was confirmed using the Agilent 2100
Bioanalyzer and spectrophotometric methods. RNA was amplified
using the NuGen Ovation RNA Amplification System V2,
fragmented and labelled using the FL-Ovation cDNA Biotin
Module V2 (NuGen, San Carlos, CA, USA), and hybridised to the
Affimetrix GeneChip chicken genome microarray in accordance
with NuGen guidelines. Array hybridisation was performed in
triplicate using three independent RNA samples from each cell
line. Raw data excel files were imported into GeneSpring GX 7.3
(Agilent Technologies) using RMA preprocessing, before per-chip
(normalised to 50
th percentile) and per-gene (normalised to median
signal) normalisations were performed. Non-expressed genes were
removed by filtering on control signal using the cross-gene error
model. Genes whose differential expression was significant were
identified using Welch’s approximate t-test, with a Benjamini and
Hochberg false discovery rate of 5% and a fold change cutoff
of 1.5.
All microarray data is MIAME compliant, as detailed on the
MGED Society website http://www.mged.org/Workgroups/
MIAME/miame.html. The raw data has been deposited in the
MIAME compliant database ArrayExpress (http://www.ebi.ac.
uk/microarray-as/ae/) under accession numbers E-MEXP-2721
(WT clone18 vs 53Bp1
2/2 comparison) and E-MEXP-2722 (WT
clone18 vs Dot1L
2/2 comparison). Data have been released in the
public domain upon acceptance of this manuscript.
Reverse transcription followed by quantitative real-time
PCR
RNA samples were prepared from cells using TriReagent
(Invitrogen, Paisley, UK). Quantitative real-time PCR was
performed using the Applied Biosciences 7500-Fast system and
the Applied Biosystems real-time PCR Sybr Green master mix
(Applied Biosystems, Warrington, UK). All reactions were
performed in triplicate. The complete list of primers used is
provided in Supplementary Table S1.
Fluorescence Activated Flow Cytometry (FACS)
To analyse DNA content, cells were fixed in 70% ethanol at
220uC. Cells were then stained using propidium iodide (Sigma,
Dublin, Ireland), and analysed using the FACS Calibur platform
and CellQuest software (BD Biosciences, Belgium).
Results
Generation of the Dot1L
md/md cell line
The SAM binding domain is essential for the HMTase activity
of both budding yeast Dot1 and human DOT1L [7,8,13,16]. This
fact was exploited to generate a cell line lacking Dot1L activity.
The SAM binding domain is encoded by exons 5, 6, and 9. We
designed a strategy to disrupt exons 5 and 6 by deleting a portion
of these exons and integrating in-frame stop codons into both
exons to disrupt translation of downstream sequences (Figure 1A).
Integration of the resistance cassette should also perturb the
reading frame of downstream sequences. In total, 3.4 kb of
genomic sequence, corresponding to 245 RNA nucleotides or 83
amino acids, were deleted from the Dot1L gene. Our gene
targeting strategy was predicted to generate a cell line, initially
termed Dot1L
md/md, in which Dot1L is methyltransferase deficient.
Targeting was performed in two DT40 wild-type backgrounds,
WT18 [38] and Cre1-DT40, in which the Cre recombinase is
stably integrated (see cell lines section of material and methods)
[40]. In addition, targeting was also carried out in 53Bp1
2/2 cell
lines generated in the WT18 [44] and Cre1-DT40 (data not
shown) backgrounds. Phenotypic analysis was carried out in both
sets of cell lines (see cell lines section of material and methods).
With the exception of the quantification of foci, which was
performed in Cre1-DT40 backgrounds (Figures 4, S6 and S7),
results obtained in the DT40 WT18 background cell lines are
presented here.
Drug-resistant clones were screened by Southern blotting to
identify targeted integration events (Figure 1B). As expected, a
single band of 13 kb was detected in WT cells (lane 1).
Heterozygous Dot1L
+/md clones generated following transfection
with the neomycin knockout construct were identified by detection
of two bands: the WT band of 13 kb, and a 16 kb band
corresponding to the targeted allele (lane 2). Integration of the
hygromycin knockout construct at the remaining WT locus was
demonstrated by the disappearance of the 13kb WT band, and the
appearance of a correctly targeted 12 kb band (lane 3).
Reverse transcription PCR (RT-PCR) was performed to
characterise Dot1L expression in Dot1L
md/md cells (Figure 1C).
Primers were designed to amplify the exons indicated in Figure 1C.
As expected, expression of exons 2–4 was detected in both WT
and Dot1L
md/md cell lines (lanes 1 and 2). Transcription of exons
downstream of the targeted integration site was detected in
Dot1L
md/md cells (lanes 5 and 6). In addition, transcription of exons
2 to 10, encompassing the targeted exons 5 and 6, was also
detected in WT and Dot1L
md/md cells, although the latter produced
a shorter product (lanes 3 and 4). Sequencing of the RT-PCR
products demonstrated that the Dot1L mRNA from Dot1L
md/md
cells contained exons 2–4 and exons 7–10, but lacked all of exons 5
and 6. Indeed it was possible to amplify the Dot1L transcript from
exons 2 to 29 from Dot1L
md/md cells (lane 8) suggesting the
possibility of in-frame translation of sequences located upstream
and downstream of the targeted region. In conclusion, a splicing
event of exons 5 and 6 was generated by the introduction of the
targeted construct.
To determine the level of Dot1L expression in our Dot1L
md/md
cells, we analysed Dot1L RNA levels in a quantitative manner
using RT-PCR. Expression of Dot1L sequences downstream of the
targeted site was reduced roughly 1000-fold in two independent
Dot1L
md/md cell lines (Figure 1D). Thus, not only had our gene
targeting strategy successfully removed exons 5 and 6, which
encode the SAM binding domain, it also severely reduced
expression of a Dot1L mRNA containing an internal stop codon.
Therefore, we re-designated our Dot1L
md/md cells as Dot1L
2/2 cells
to indicate defective gene function.
H3K79 methylation in Dot1L
2/2 cells
To investigate whether the Dot1L
2/2 cell lines were indeed
deficient in Dot1L HMTase activity, the level of H3K79
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antibody supposedly directed against H3K79me2. While H3K79
methylation was readily detected in WT cells (Figure 2A, lane 1),
no methylation of this residue was detected in Dot1L
2/2 cells (lane
2), even after blot overexposure. Note that this antibody also
recognises H3K79me1 to a lesser extent (Figure S1B and see next
section). We also attempted to perform western blots for H3K79
mono- and trimethylation. However, the antibody against
H3K79me1 cross-reacted with unmodified recombinant histone
H3 (Figure S1A), and H3K79me3 could not be detected in WT or
Dot1L
2/2 cells (data not shown).
Mass spectrometry (MS) was performed to determine the
impact of Dot1L gene disruption on H3K79 mono-, di-, and
trimethylation. Histones were acid-extracted from asynchronous
populations of wild-type (WT) and Dot1L
2/2 cells. Intact core
histones were further purified by reversed-phase HPLC. Purified
H3 was propionylated to block trypsin digestion at non-modified
and mono-methylated K79. After propionylation (pr), trypsin
digestion generates four peptides of the same length that include
K79. These peptides correspond to the unmodified (me0 pr1),
mono- (me1 pr1), di- (me2 pr0) and tri-methylated (me3 pr0) forms
of H3K79. They can all be readily distinguished based on their
mass-to-charge ratio. After propionylation, tryptic digests were
analysed by nanoLC-MS/MS. The fractions of total H3 that are
mono-, di- or tri-methylated at K79 was quantified by multiple
reaction monitoring [46] and are shown in Figure 2E. The
fragmentation and precursor ion spectra of the propionylated
peptide containing H3K79me1 (me1 pr1) are shown in Figures 2B
and 2C, respectively. Mono-methylation (me1 pr1) of H3K79 was
by far the most abundant methylated species in WT cells where it
represents approximately 10% of total H3 (Figure 2E). This is a
substantial figure which implies that, on average, an H3K79me1
molecule is present every five nucleosomes. Intriguingly, using
either product ion scans or MRM, H3K79me2 was present in low
amounts (not shown in Figure 2) and H3K79me3 was not detected
in total histones prepared from wild-type DT40 cells. The low
amount of H3K79me2 present was surprising given the strong
H3K79me2 signal detected by western blotting (Figure 2A).
However, using a peptide competition experiment we found that
the antibody used here (Figure 2A) is not entirely specific to
dimethylated H3K79 and probably cross-reacts with this residue
when it is monomethylated (Figure S1B). This likely explains the
strong signal detected in Figure 2A since, based on MS, the
monomethylated form is present at nearly 150-fold greater
abundance than the dimethylated form (Figure 2E). The MRM
search list included precursor ions corresponding to the four
modified states of H3K79 described above. Although MRM is
very sensitive [45], it failed to identify ions that contained
H3K79me3 in spite of the fact that the ions corresponding to
unmethylated (pr1) and mono-methylated K79 (me1 pr1) were
highly abundant (data not shown). We therefore conclude that
H3K79me3 is either absent or present in very small amounts in
wild-type DT40 cells. This is not unique to chicken DT40 cells;
similar results were previously reported in total histones isolated
from asynchronous populations of HeLa [47] and mouse ES cells
[35]. In Dot1L
2/2 cells, essentially all H3K79me2 was absent
(Figure 2E) and only a very small amount of H3K79me1 remained
(Figures 2D and E).
Human DOT1L complements Dot1L deficiency in chicken
DT40 cells
To prove that the absence of H3K79 methylation was due to
disruption of Dot1L, an expression vector containing a hDOT1L
cDNA [7] was transiently transfected into Dot1L
2/2 cells. Due to
the high level of conservation between human and chicken histone
H3 and Dot1L (Figure S2), we predicted that human DOT1L
would methylate H3K79 in chicken cells. Indeed, hDOT1L was
previously found to methylate chicken nucleosomes in vitro [16]. As
shown in Figure 2F, transfection of the hDOT1L expression
construct into DT40 Dot1L
2/2 cells resulted in an increase in
H3K79 methylation (lane 1) compared to transfection with the
corresponding empty vector (lane 2).
Dot1L deficiency does not affect histone H4 lysine 20
methylation
Both H3K79 and H4K20 methylation (H4K20me) have been
implicated in the DNA damage response [20,21,22,25,29].
Because of this, we sought to determine whether disruption of
the Dot1L gene had any influence on global levels of H4K20me.
This was technically challenging because the short tryptic peptide
containing H4K20 (20- KVLR -23) did not bind to our reversed-
phase HPLC column even after propionylation. To circumvent
this retention issue, we used an MS strategy that bypasses the need
to separate tryptic peptides by reversed-phase HPLC prior to their
detection in the mass spectrometer. This approach, known as
high-field asymmetric waveform ion mobility spectrometry
(FAIMS), separates precursor ions in the gas phase [48]. Histone
H4 was propionylated to prevent cleavage at unmodified or mono-
methylated lysine 20, digested with trypsin, and the resulting
peptides were infused into a FAIMS unit coupled to an Orbitrap
mass spectrometer. Using FAIMS, we readily detected a doubly
charged precursor ion with m/z 272.20 corresponding to a
dimethylated form of the H4 peptide (20- Kme2VLR -23) (Figure
S3). The fragmentation spectrum of this precursor ion confirmed
its identity and the presence of H4 K20 dimethylation (Figure S4).
Unexpectedly, although H4 molecules with other degrees of K20
methylation (including H4 molecules that were not K20-
methylated) may well exist in DT40 cells, they were not detected
in our FAIMS analysis, which suggests that they are far less
abundant than H4K20me2. Using a mixture of four synthetic
peptides (corresponding to H4K20me0, me1, me2 and me3) that
was subjected to propionylation and trypsin digestion, we found
that the H4K20me0, me1 and me3 peptides were readily detected
using the FAIMS-Orbitrap instrument. Moreover, there was no
strong bias in favour of detection of H4K20me2 (data not shown).
This demonstrates that the vast majority of H4 molecules are K20-
dimethylated in wild-type DT40 cells. Importantly, when
normalised to those of a non-modified H4 peptide (not derived
from the region containing H4K20), H4K20me2 ion counts were
equally abundant in wild-type and Dot1L-deficient cells (Figure
S5). Thus, the phenotypes of cells lacking Dot1L cannot be
attributed to changes in H4 K20 dimethylation.
Dot1L deficiency results in proliferation defects in DT40
cells
Cellular proliferation was examined by monitoring the increase
in cell number over time. Dot1L
2/2 cells exhibited a mild
proliferation defect (Figures 3A and 3B), which was also apparent
when doubling times were calculated (Figure 3C). Analysis of cell
cycle distribution revealed that disruption of Dot1L alone did not
greatly affect cell cycle stage distribution in asynchronously
proliferating cells (Figure 3D). However a slight increase in the
sub-G1 population, which corresponds to dead cells, was observed
(Figure 3D). A slight increase in cell death in the absence of
functional Dot1L has previously been reported [35].
We have previously reported a mild proliferation defect in
53Bp1 defective DT40 cells [44]. Since Dot1L and H3K79
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2/2 cells. A. Western blot showing the loss of H3K79 dimethylation in Dot1L
2/2
cells. The membrane was stripped and reprobed with an antibody against total H3 to demonstrate equivalent loading. B. Collision-induced
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damage response [20], we asked whether the slow proliferation of
Dot1L
2/2 cells was due to perturbation of a 53Bp1 pathway. To
achieve this, the proliferation rate of the 53Bp1
2/2/Dot1L
2/2 cell
line, defective in both 53Bp1 and Dot1L, was studied. Interest-
ingly, knockout of Dot1L in the 53Bp1
2/2 cell line led to a severe
proliferation defect: 53Bp1
2/2/Dot1L
2/2 cultures did not prolif-
erate at all when seeded at a low cell density (Figure 3A), and grew
at a slower rate than WT cells or either of the single mutants when
seeded at higher cell density (Figure 3B and 3C). A significant
increase in the sub-G1 peak was also observed in 53Bp1
2/2/
Dot1L
2/2 cells (Figure 3D). This suggests that increased levels of
cell death occur in the absence of both 53Bp1 and Dot1L,
which likely contributes to the pronounced proliferation defect of
this cell line.
53Bp1 focal recruitment and resistance to ionising
radiation in Dot1L defective DT40 cells
We next investigated the formation of ionising radiation (IR)-
induced foci in cells lacking H3K79 methylation. The formation of
foci containing the phosphorylated form of the H2AX histone
variant (c-H2AX), an excellent surrogate marker of DNA double-
Figure 3. Proliferation and cell cycle distribution of Dot1L-deficient cells. A and B. Cell proliferation of cultures seeded at 1610
4 cells/ml (A)
and 1610
5 cells/ml (B). C. Measured doubling times. D. Cell cycle distribution monitored by propidium iodide staining of DNA and flow cytometry.
Arrows indicate sub-G1 populations.
doi:10.1371/journal.pone.0014714.g003
fragmentation spectrum of precursor ion m/z 706.37
2+ (shown in C). The spectrum shows a nearly complete y-ion series. The mass difference between
the y4 and y6-ion confirms the presence of a single propionyl and methyl group on H3K79 (pr1+me1). C. Doubly charged precursor ion with the
measured m/z ratio expected for peptide EIAQDFK79(pr1+me1)TDLR. The monoisotopic peak containing only
12C atoms (arrow) and those containing a
single
13C (*) or two naturally occurring
13C atoms (**) are shown. D. Extracted ion chromatograms (XIC) showing the abundance of the doubly
charged precursor peptide containing H3K79me1 (pr1+me1) in WT and Dot1L
2/2 cells. E. Relative abundance of the various H3K79 methylation states
determined by MRM mass spectrometry in total histones isolated from WT and Dot1L
2/2 cells. ND: not detected. F. Western blot showing that the
absence of H3K79me2 in Dot1L
2/2 cells can be complemented by transient transfection of plasmid containing the human Dot1L cDNA.
doi:10.1371/journal.pone.0014714.g002
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2/2 cells (Figure 4A).
In addition, the absence of Dot1L did not enhance the number of
c-H2AX after irradiation of 53Bp1
2/2 cells (Figure S6).
To determine if H3K79 methylation is required for the
recruitment of 53Bp1 to sites of DNA damage, we performed a
detailed dose response and time course analysis of 53Bp1 foci
formation in DT40-Cre1 and isogenic Dot1L
2/2 cells by
immunofluorescence microscopy following IR. Despite a slight
delay in 53Bp1 foci disappearance at late time points, DT40-Cre1
cells behaved identically to WT cells regarding the kinetics of
53Bp1 accumulation (Figure S7). We observed 53Bp1 focal
recruitment in the absence of functional Dot1L at all IR doses
and time points tested (Figure 4A). To determine if subtle
differences in 53Bp1 recruitment did occur in Dot1L
2/2 cells, the
mean number of 53Bp1 foci per cell, and the percentage of cells
containing 53Bp1 foci were counted. At several doses of IR, the
absence of Dot1L and H3K79 methylation did not alter the
number of 53Bp1 foci formed per cell (Figure 4B), nor the mean
number of cells containing foci (Figure S7E). We also investigated
the kinetics of 53Bp1 focal recruitment in the absence of Dot1L.
Dot1L
2/2 and WT cells were indistinguishable in 53Bp1 focal
recruitment and persistence of foci at all time points tested. This
was true in terms of the number of 53Bp1 foci per cell (Figures 4 C
and D) and the mean number of cells with foci (Figure S7).
Sensitivity to DNA damaging agents, which is indicative of
DNA repair capability, was also investigated. We have previously
reported that 53Bp1 functions in the non-homologous end-joining
(NHEJ) DNA double-strand break repair pathway in DT40 cells.
53Bp1-deficient DT40 cells are moderately sensitive to low doses
of IR, but resistant to higher doses [44]. Unlike 53Bp1
2/2 cells,
Dot1L
2/2 cells were not sensitive to IR, suggesting that these cells
are not defective in repair of IR-induced DNA lesions (Figure 5).
This is in agreement with results shown in Figures 4C and S7, in
which 53Bp1 foci disperse at similar rates in Dot1L-deficient and
WT cells. Disappearance of DNA damage foci is thought to cor-
relate with completion of DNA repair. Intriguingly, 53Bp1
2/2/
Dot1L
2/2 cells exhibited significantly better survival than the
53Bp1
2/2 single mutant at low doses of IR (Figure 5). At doses of
Figure 4. Recruitment of 53Bp1 to nuclear foci following ionising radiation. A. Representative images of 53Bp1 and cH2AX foci obtained by
immunofluorescence microscopy in WT and isogenic Dot1L
2/2 cells (Cre1 DT40 background). B. Recruitment of 53Bp1 to foci in response to
increasing doses of IR was monitored 30 minutes following IR. The number of 53Bp1 foci per cell was counted. 50–100 cells were analysed per data
point. C. Kinetics of 53Bp1 foci formation. The number of 53Bp1 foci per cell was counted at the indicated time points following exposure to 15Gy of
IR. 50–100 cells were counted per data point. The left panel shows the number of foci per cell from 15 minutes up to 2 hours following IR. The right
panel shows the number of 53Bp1 foci per cell from 2 hours up to 6 hours following IR. These quantifications have been obtained from experiments
performed on Cre1 DT40 background cell lines.
doi:10.1371/journal.pone.0014714.g004
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2/2/Dot1L
2/2 cells are even more
resistant than WT cells (Figure 5). These results indicate that
mutation of Dot1L reduces IR-induced cell death in the absence of
53Bp1.
Dot1L affects expression of many genes
Because Dot1L is implicated in the regulation of gene
expression, we decided to determine the RNA expression profile
of Dot1L
2/2 cells by microarray analysis. RNA was prepared from
WT18 and isogenic Dot1L
2/2 DT40 cells and hybridised to
Affymetrix Chicken GeneChips. Disruption of Dot1L had a
dramatic effect on gene expression. The levels of RNAs derived
from approximately 1200 genes were significantly altered (more
than 1.5-fold) in the absence of functional Dot1L. 74% of these
RNAs were upregulated and 26% downregulated in Dot1L
2/2
cells (Figure 6A and B). The majority of these RNAs displayed a
1.5- to 10-fold differential expression (Figure 6B). We also
observed 48 RNAs whose expression levels were elevated by more
than 50-fold (Figure 6B). Microarray results were confirmed by
reverse transcription and quantitative real-time PCR (RT-qPCR)
on candidate RNAs selected on the basis of fold-change
upregulation or downregulation (Figure 6C). While the fold
change observed by RT-qPCR was in most cases greater than that
observed by microarray, the two approaches generated qualita-
tively similar results (Figure 6C, Table). RT-qPCR analysis of the
Etv1 RNA, which displayed the highest level of upregulation in the
absence of Dot1L, showed that this RNA was almost undetectable
in WT cells, whereas Etv1 transcripts were readily detectable in
Dot1L
2/2cells. The same was true for another candidate RNA
tested, Pparc. This raises the possibility that these genes may be
repressed in WT, and transcriptionally active in Dot1L
2/2 cells,
although other mechanisms of RNA regulation could also be
involved. Conversely, the Elolv7 and SetBp1 RNAs were almost
undetectable in Dot1L
2/2 cells, but were readily detected in WT
cells. This likely indicates that these genes are transcriptionally
active under normal cellular conditions, but are not expressed in
the absence of Dot1L. The Lig4 and H-ras RNAs, which exhibit
lower levels of differential expression, were easily detectable in
both cell lines. Similar RT-qPCR results were obtained using
Dot1L-deficient cells in the DT40-Cre1 background (data not
shown).
To further understand the biological relevance of this altered
RNA expression profile, a gene ontology (GO) analysis was
performed. In agreement with the phenotypes observed in
Dot1L
2/2 cells, GO groups related to cell proliferation, cell cycle
progression and apoptosis were statistically overrepresented in the
list of differentially expressed RNAs (Table 1 and Tables S2 and
S3). Dot1L is essential for embryonic development and knockout
of Dot1L is lethal in mice [21,35]. In this respect it is interesting to
note that groups of genes functioning in development and
differentiation were also overrepresented in the list of differentially
expressed genes.
RNA expression profiling was also previously carried out in
mouse ES cells in which Dot1L was stably knocked down using
shRNA [49]. Strikingly, 12% of the RNAs, corresponding to an
identified gene, abnormally expressed in Dot1L knockdown ES
cells were also misregulated in the Dot1L
2/2 DT40 cells (see Table
S4 for a comparison of the two studies) and similar gene ontology
groups were overrepresented. This indicates that the role of Dot1L
in the regulation of gene expression is conserved across vertebrate
species and distinct cell types. However, we observed that twice as
many genes were misregulated in the absence of Dot1L in DT40
cells compared with Dot1L knockdown in mouse ES cells, possibly
due to residual Dot1L activity resulting from incomplete
knockdown (Table S4). Despite this, in both systems, approxi-
mately 74% of the differentially expressed RNAs were upregulated
in Dot1L-deficient cells (Table S4).
53BP1 interacts with H3K79 methylation [20] and also affects
gene expression. The protein binds to the BRCA1 promoter in
human cells and siRNA depletion of 53BP1 results in reduced
BRCA1 mRNA and protein levels [50]. 53BP1 also binds to the
tumor suppressor protein p53 and enhances p53-dependent
transcription [51,52]. We performed a microarray analysis on
the 53Bp1
2/2 cell line to determine the impact of 53Bp1 on the
global RNA expression profile of DT40 cells. We found that
approximately 311 RNAs (compared to 1267 in Dot1L
2/2 cells)
were differentially expressed between 53Bp1
2/2and WT cells,
with equal number of RNAs upregulated and downregulated
(Figure 6D and E). GO analysis showed that many of these RNAs
were involved in the immune response and apoptosis (Tables S5
and S6).
In an attempt to explain the more pronounced cell death and
proliferation defect observed in the 53Bp1
2/2/Dot1L
2/2 cell line
(Figure 3), we compared the RNAs whose expression was affected
in the Dot1L
2/2 and 53Bp1
2/2 single mutant cells (Figure 6F).
135 of the RNAs inappropriately expressed in 53Bp1
2/2 cells
were also misregulated in Dot1L
2/2 cells. This represents 43% of
the differentially expressed RNAs in 53Bp1
2/2 cells and 10% of
the RNAs whose expression is altered in Dot1L
2/2 cells. The fact
that the majority of misregulated RNAs do not overlap is
consistent with the additive defects observed in 53Bp1
2/2/
Dot1L
2/2 cells.
In budding yeast, deletion of DOT1 leads to silencing defects of
reporter genes integrated into sub-telomeric heterochromatin
[13,31,32,34]. Based on this, we hypothesised that the genes
Figure 5. Cell survival following DNA damage caused by
ionising radiation. Clonogenic survival of WT, Dot1L
2/2, 53Bp1
2/2,
and 53Bp1
2/2/Dot1L
2/2 cell lines treated with increasing doses of IR.
The experiment was carried out three times, error bars show standard
deviation.
doi:10.1371/journal.pone.0014714.g005
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chromosomal regions that are either heterochromatic or euchro-
matic in WT DT40 cells. Although we did not observe any
statistically significant clustering of the affected genes (data not
shown), we noticed that all but one of the twelve RNAs
upregulated by more than 100-fold in cells lacking Dot1L
(Figure 6B) were encoded by genes present on macrochromo-
somes. In chicken, the genome consists of 6 pairs of macro-
chromosomes, and 30 pairs of microchromosomes [53]. 48% of
the genes in chicken are present on macrochromosomes [54].
However, 92% (11 out of 12) of the RNAs that are highly
upregulated in the absence of Dot1L are encoded by genes on
macrochromosomes. Interestingly, the macrochromsomes are
relatively gene-poor compared to the microchromosomes. In
addition, genes on macrochromosomes are transcribed at
relatively low levels and preferentially located near the periphery
of the nucleus [54,55].
Discussion
We generated and characterised novel vertebrate cell lines in
which the Dot1L histone methyltransferase gene has been
disrupted. This was achieved by knocking out part of the
SAM binding domain of the chicken DT40 gene, which is
essential for Dot1L methyltransferase function. We showed
that residual levels of Dot1L expression are extremely low in
these cells. Importantly, the residual Dot1L transcripts lack
sequences corresponding to exons 5 and 6, which encode
the SAM binding domain necessary for enzyme activity.
Western blotting and mass spectrometry demonstrated a
Figure 6. Regulation of gene expression by Dot1L. A. Heat map showing changes in gene expression caused by Dot1L deficiency. In the
columns depicting expression data from Dot1L
2/
2 cells, red indicates RNAs that are upregulated in the absence of Dot1L, and green indicates RNAs
that are downregulated in the absence of Dot1L. A fold-change cut-off of 1.5 was used. Three technical replicates (numbered 1, 2, and 3) are shown
for each cell line. B. Number of RNAs up or downregulated at the indicated fold-change cut-off values in Dot1L
2/2 cells. C. Validation of Dot1L
2/2
microarray results by RT-qPCR. The graph shows fold change values obtained from qPCR. The table compares fold change values determined using
either microarrays or RT-qPCR. Candidate RNAs were chosen to represent the range of fold change up or downregulation observed in the microarray
analysis. D. Heat map showing changes in gene expression caused by 53Bp1 deficiency. A fold-change cut-off of 1.5 was used. Three technical
replicates (numbered 1, 2, and 3) are shown for each cell line. E. Number of genes up or downregulated at the indicated fold-change cut-off values in
53Bp1
2/2 cells. F. Overlap of RNAs displaying altered expression levels between WT cells and either 53Bp1
2/2 or Dot1L
2/2cells.
doi:10.1371/journal.pone.0014714.g006
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2/2
cells: H3K79me2 was undetectable and H3K79me1 was
drastically reduced.
Dot1L has previously been disrupted in mouse embryonic stem
cells using a targeting strategy similar to that employed here [35].
H3K79me1 and H3K79me3 were undetectable. However, a small
amount of residual H3K79me2 was reported. The authors
postulated that this might be due to contamination from feeder
cells necessary to culture ES cells. While it is clear that Dot1L is
the main H3K79 methyltransferase in DT40 cells (Figure 2E), we
also detect a small amount of residual H3K79me1 in Dot1L
2/2
cells. Since our model system does not require the presence of
feeder cells, residual H3K79me1 cannot be ascribed to contami-
nation of the Dot1L
2/2 culture. An exciting possibility is that an
enzyme other than Dot1L is capable of mono-methylating H3K79
on a very small portion of histone H3 molecules. However, we
cannot exclude the possibility that the residual H3K79me1 is not
physiologically relevant. For example, it may represent a fortuitous
off-target product of another methyltransferase with a preference
for lysine residues other than H3K79. Alternatively, the low level of
residual H3K79me1 in Dot1L-deficient cells may arise through
non-enzymatic methylation [56].
Abrogation of Dot1L methyltransferase activity caused defects
in DT40 cell proliferation. Dot1L
2/2 cells grew at a slower rate
than WT cells and flow cytometry analysis suggested increased
levels of cell death. It has also been reported that Dot1L is
required for normal progression through the cell cycle in mouse
ES cells [35,49], budding yeast [57] and T. brucei [58], indicating
that some functions of Dot1L are conserved across species and
cell types. However, there are also important differences between
DT40 and mouse ES cells. First, in contrast to mouse ES cells,
H3K79me1 is by far the most prevalent form of H3K79
methylation in DT40 cells. Second, aneuploidy has been reported
in Dot1L-deficient mouse ES cells. Most aneuploid ES cells
possessed chromosome contents greater than 4N [35,59].
However, flow cytometry of Dot1L
2/2 DT40 cells did not reveal
an increased number of cells with a greater than 4N DNA
content (Figure 3D). ES cells have less stringent cell cycle
checkpoints than differentiated cells [49]. This might explain why
DT40 Dot1L
2/2 cells do not display any obvious increase in
ploidy.
The slight increase in dead cells and slow proliferation of
Dot1L
2/2 cells might be due to alterations in gene expression.
Based on microarray analysis, we found over 1200 RNAs whose
expression is perturbed by the absence of Dot1L. 74% of these
RNAs were overexpressed in Dot1L
2/2 cells, which is consistent
with a role for Dot1L in gene silencing and the maintenance of
heterochromatin structure. However a significant number of
RNAs (26%) were underexpressed in Dot1L
2/2cells. These
findings are in agreement with the fact that methylation of
H3K79 has been reported to cause both gene activation and
repression at different loci [36,60].
Histone methylation plays an important role in the DNA
damage response by contributing to the recruitment of 53BP1
to damaged chromatin. However, much uncertainty did
surround the role of H3K79 methylation in the focal recruitment
of 53BP1 to sites of DNA damage. The detailed studies that we
performed in Dot1L
2/2 DT40 cells show that H3K79 methyl-
ation is not required for 53Bp1 recruitment to sites of DNA
double-strand breaks at the time points and IR doses that we
tested. Our results are in agreement with the previously reported
role of H4K20me [21,28], rather than H3K79me, in 53BP1
recruitment to sites of DNA damage. However, it is also possible
that, in vivo, these two methylation marks function redundantly in
53BP1 recruitment. As stated in the introduction, the function of
53BP1 homologues in budding and fission yeast respectively
Table 1. Representative sample of gene ontology groups regulated by Dot1L.
GO Term GO Group % total genes/GO
% regulated
genes/GO p-value
Upregulated in the absence of Dot1L
30323 Respiratory tube development 0.137 1.881 2.82610
26
48015 Phosphoinositide-mediated signaling 0.388 2.508 2.82610
25
9653 Morphogenesis 1.924 5.643 4.58610
25
19882 Antigen presentation 0.312 2.194 5.12610
25
30900 Forebrain development 0.144 1.567 7.15610
25
7275 Development 6.288 11.91 1.1610
24
1558 Regulation of cell growth 0.289 1.881 2.79610
24
45639 Positive regulation of myeloid cell differentiation 0.0152 0.627 5.86610
24
1944 Vasculature development 0.312 1.576 0.0029
6979 Response to oxidative stress 0.342 1.576 0.0049
Downregulated in the absence of Dot1L
50803 Regulation of synapse structure and function 0.0228 1.653 2.50610
24
46689 Response to mercury ion 0.038 1.653 8.25610
24
7264 Small GTPase mediated signal transduction 4.015 10.74 0.0011
6915 Apoptosis 1.719 6.612 0.0011
10035 Response to inorganic substance 0.0608 1.653 0.0023
% total genes/GO indicates the percentage of genes in the GO groups specified in the chicken genome.
% regulated genes/GO indicates the percentage of genes in the specified GO groups that were present in the list of genes whose expression was perturbed in cells
lacking Dot1L.
doi:10.1371/journal.pone.0014714.t001
Functions of Dot1L and 53Bp1
PLoS ONE | www.plosone.org 12 February 2011 | Volume 6 | Issue 2 | e14714depends upon H3K79me and H4K20me. This is because only
one of the two modifications exists in each yeast model organism.
During the course of evolution, vertebrate cells may have
retained a function for both types of histone methylation in
modulating the recruitment of 53BP1 to damaged chromatin
either under specific physiological conditions (e.g. different types
of DNA lesions) or at distinct loci. This might be consistent with
the fact that H3K79me and H4K20me affect chromatin
structure in fundamentally different ways [61]. Importantly, the
greater abundance of methylated histone H4K20 over H3K79
methylation is consistent with the former modification playing a
more prominent role in 53Bp1 recruitment and this is consistent
with our observations that Dot1L-deficient cells are not defective
in 53Bp1 foci formation. Further work is required to fully
elucidate the relative contribution of these two modifications in
the DNA damage response.
53BP1 promotes the repair of DNA double-strand breaks by
NHEJ [44,62]. However, DNA double-strand break repair
pathways must be functional in the absence of Dot1L since
Dot1L-deficient DT40 cells are not sensitive to ionizing radiation.
This suggests that H3K79 methylation is not required for the role
of 53Bp1 in NHEJ in DT40 cells. However, moderate DNA
damage sensitivity has been reported in mouse and human cells
lacking DOT1L activity [59]. In contrast, the 53Bp1
2/2/Dot1L
2/2
cell line displayed two surprising phenotypes following IR-
induced DNA damage. First, at low doses of IR, the Dot1L
2/2
mutation rescued the IR sensitivity of 53Bp1
2/2cells that are
defective in NHEJ (Figure 5). Second, 53Bp1
2/2/Dot1L
2/2 cells
were even more resistant than WT cells to high doses of IR. One
possibilityisthattheincreasedIRresistanceofcellsdeficientinboth
53Bp1 and Dot1L is a consequence of altered gene expression.
Another possibility is that perturbation of heterochromatin
structure caused by Dot1L deficiency [35] improves the accessibil-
ity of damaged DNA to repair proteins. Although 53BP1 is not a
component of the core NHEJ machinery, it is required for a subset
of NHEJ repair events [63,64]. In response to DNA damage,
53BP1 is needed for ATM-dependent phosphorylation of the
transcription repressor protein KAP1 [62,65]. KAP1 directly binds
to members of the HP1 protein family and other histone-modifying
enzymes that promote heterochromatin formation [63]. Phosphor-
ylation by ATM inactivates KAP1, which leads to a more open
heterochromatin structure and facilitates DNA repair [63,65].
Because Dot1L contributes to heterochromatin structure in mouse
ES cells [35], it is conceivable that partial disruption of
heterochromatin structure in Dot1L
2/2 DT40 cells might alleviate
the needfor 53Bp1inKap1regulation,therebyfacilitatingrepairof
DNA breaks by NHEJ in facultative or constitutive heterochro-
matic regions (Figure S7). This would explain the rescue of IR
resistance in 53Bp1-defective cells where Dot1L is also mutated
(Figure 5). It has recently been shown that 53BP1 negatively affects
HR [66,67] and mutations that disrupt chromatin structure
enhance the efficiency of HR in yeast and mouse cells [68,69]. In
the double mutant, 53Bp1-dependent inhibition of HR will be
relieved and absence of Dot1L will result in disrupted hetero-
chromatin that will facilitate NHEJ, independently of the 53Bp1/
Kap1 pathway.
In conclusion, we find that Dot1L and H3K79 methylation are
required for normal cellular proliferation. Dot1L also strongly
influences gene expression. However, Dot1L does not play a major
non-redundant role in the focal recruitment of 53Bp1, nor does it
function directly in the repair of IR-induced DNA damage. In
contrast, in DT40 cells and in the absence of 53Bp1, Dot1L exerts
a negative effect on the ability of cells to survive DNA lesions
caused by IR.
Supporting Information
Figure S1 Cross-reaction of antibodies. A. Cross-reaction of
antibody recognizing H3K79 monomethylation with unmethy-
lated histone H3. Western blotting was performed on histones
prepared from WT and Dot1L
2/2 cell lines, as well as
recombinant histone H3 as a negative control (upper panel).
The western blot was stripped and reprobed with an antibody
against total histone H3 to demonstrate equivalent loading (lower
panel). B. A mono-methylated histone H3K79 peptide blocks the
western blotting signal generated by an antibody supposedly
specific for dimethylated H3K79. Western blotting was performed
on acid extracted histones prepared from WT and Dot1L
2/2 cell
lines. Blots were incubated with the antibody against H3K79me2
and different amounts of either H3K79me2 or H3K79me1
peptide as indicated by the peptide/antibody molar ratio. One
blot was probed with an antibody against total histone H3 to
demonstrate equivalent loading. Similar results were obtained with
histones from whole cell extracts (not shown).
Found at: doi:10.1371/journal.pone.0014714.s001 (0.87 MB EPS)
Figure S2 Dot1L is conserved in chicken. Alignment of human
and chicken Dot1L. Sequences exhibit 73% identity and 92%
similarity. Exons are highlighted by alternating blue and black fonts.
Amino acids highlighted in red interact with SAM [7,16]. Amino
acids highlighted in green are required for full HMTase activity of
hDot1L[16].The underlinedsequencerepresents the region deleted
in the Dot1L
2/2 cell line. Note that the sequence of the chicken
genome is still missing Exon 1 of Dot1L. Therefore, the N-terminal
sequence of the chicken Dot1L protein is currently unknown.
Found at: doi:10.1371/journal.pone.0014714.s002 (1.45 MB EPS)
Figure S3 FAIMS-MS detection of H4K20 dimethylation. The
mass spectrum shows a doubly charged precursor ion with an m/z
ratio of 272.20 that closely matches the m/z ratio predicted for
peptide H4 20-(Kme2 VLR)-23 (where me2 is dimethylation of the
lysine e-amino group). The other peaks correspond to the same
doubly charged precursor peptide containing either one (m/z
272.70) or two (m/z 273.22) naturally occurring
13C atoms.
Found at: doi:10.1371/journal.pone.0014714.s003 (0.26 MB EPS)
Figure S4 FAIMS-MS/MS detection of H4K20 dimethylation-
collision-induced fragmentation spectrum. Collision-induced frag-
mentation spectrum of the doubly charged precursor ion with m/z
ratio 272.20 shown in Figure S3. The y1, y2 and y3-ions confirm
the sequence H4 21-(VLR)-23 and the b3-ion is consistent with a
di-methyl lysine in the sequence H4 20-(K20me2VL)-22 (wherein
me2 is a dimethylation of the lysine e-amino group). The abundant
m/z 249.7 ion corresponds to a neutral loss from the doubly
charged precursor peptide of approximately 45 Da. This peak
might arise from collision-induced loss of NH(CH3)2 at K20, the
guanidino group (NH2-CH-NH2) of R23 or the C-terminal
COOH.
Found at: doi:10.1371/journal.pone.0014714.s004 (0.37 MB EPS)
Figure S5 Comparison of the abundance of H4K20me2 in WT
and Dot1L
md/md cells. Extracted ion chromatograms (XIC) from
FAIMS-MS experiments showing the abundance of the tryptic
peptide 20-(Kme2VLR)-23 (precursor peptide with m/z 272.202+)
in H4 isolated from wild-type (WT) and Dot1L
md/md mutant cells.
The indicated ion counts (max intensity) for the H4 20-
(Kme2VLR)-23 peptide in WT and Dot1L
md/md cells are prior to
normalisation relative to the ion counts obtained for an H4
peptide that is not modified (DNIQGITKprPAIR). The values
obtained after normalisation are indicated above each peak and
they are within less than 1% of each other. The experiment was
repeated three times with essentially the same result. pr:
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voltage. Since no reversed-phase HPLC column was used, elution
time refers to the time required for the peptides to be infused and
travel through the FAIMS device prior to MS detection.
Found at: doi:10.1371/journal.pone.0014714.s005 (0.32 MB EPS)
Figure S6 Formation of cH2AX foci as a function of time
following 15Gy IR. Representative images of cH2AX foci obtained
by immunofluorescence microscopy before and after exposure to
ionizing radiation. Green: cH2AX, blue: DAPI. Comparison of
experiments performed with Cre1 DT40 and WT18 cells.
Found at: doi:10.1371/journal.pone.0014714.s006 (5.20 MB TIF)
Figure S7 DT 40 WT18 and Cre1 cell lines exhibit identical
formation of 53Bp1 foci following IR. A. Representative images of
53Bp1 and cH2AX foci obtained by immunofluorescence
microscopy of DT40-WT18 and Cre1 cells. Red: 53Bp1. Green:
cH2AX. Blue: DAPI. B and C. Kinetics of 53Bp1 foci formation
from 15 minutes to 2 hours following IR (B) and from 2 hours to
6 hours following IR (C) in DT40-WT18, Cre1, and Cre1
Dot1L
2/2 cells. The number of 53Bp1 foci per cell was counted
at the indicated time points following exposure to 15 Gy IR. 50–
100 cells were counted per data point. D and E. Focal recruitment
of 53Bp1 at 30 minutes following treatment with increasing doses
of IR. Both the mean number of cells with more than 6 foci per
cell (D) and the number of 53Bp1 foci per cell (E) were counted.
50–100 cells were analysed per data point.
Found at: doi:10.1371/journal.pone.0014714.s007 (2.41 MB EPS)
Figure S8 Schematic representation of the status of heterochro-
matin and DSB repair in the indicated cell lines. See text for
details.
Found at: doi:10.1371/journal.pone.0014714.s008 (2.35 MB EPS)
Table S1 Primers used for quantitative real-time PCR validation
of microarray results.
Found at: doi:10.1371/journal.pone.0014714.s009 (0.07 MB
DOCX)
Table S2 GO groups over-represented in Dot1L-upregulated
genes.
Found at: doi:10.1371/journal.pone.0014714.s010 (0.08 MB
PDF)
Table S3 GO groups over-represented in Dot1L-downregulated
genes.
Found at: doi:10.1371/journal.pone.0014714.s011 (0.08 MB
PDF)
Table S4 Comparison of the number and overlap of genes
misregulated in chicken DT40 and mouse ES Dot1L deficient cells.
1 Up and downregulated.
2 Differentially expressed entities from
chicken Dot1L
2/2 cells (this study) and Dot1L knockdown mouse
ES cells [49].
3 Number of hits from lists in
1 submitted to DAVID
Bioinformatics Resources v6.7 with returned gene names [70,71].
4 Number of genes differentially regulated in Dot1L knockdown
mouse ES cells (from
3) for which a homolog is known in chicken.
5 Numberofgenesdifferentiallyregulated inboth Dot1Lknockdown
mouse ES cells and chicken Dot1L
2/2 cells.
6 Percentage of the
mouse genes misregulated in Dot1L knockdown mouse ES cells also
misregulated in chicken Dot1L
2/2 cells expressed as: number of
genes differentially regulated in both Dot1L knockdown mouse ES
cells and chicken Dot1L
2/2 cells
5 divided by the number of genes
differentially regulated in Dot1L knockdown mouse ES cells for
which a homolog is known in chicken
4.
Found at: doi:10.1371/journal.pone.0014714.s012 (0.05 MB
DOCX)
Table S5 GO groups over-represented in 53Bp1-upregulated
genes.
Found at: doi:10.1371/journal.pone.0014714.s013 (0.07 MB
PDF)
Table S6 GO groups over-represented in 53Bp1-downregulated
genes.
Found at: doi:10.1371/journal.pone.0014714.s014 (0.07 MB
PDF)
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